S&N gets $140m off for tainted Plus buy
This article was originally published in Clinica
Executive Summary
Smith & Nephew has negotiated a 15% cut in the price it originally paid for its troubled orthopaedic reconstruction subsidiary Plus Orthopedics with the latter’s vendors.